CONTENTS:
- Managing dual dependencies: A case study of concurrent low-dose buprenorphine induction and rapid phenobarbital taper. Schnipke B., Archer G., Hanko V., Hamm B., p. 189-193.
- Patterns of opioid and NSAID use in Saudi Arabia from 2010 to 2020. Althemery A.U., Alsubaie M., Alharbi H., Alqahtani A., Alsubaie G., Alotaibi A., p. 194-199.
- Health-promoting behaviors in male patients with opioid use disorder: An exploratory study. Patel V., Negi P.S., Shah R.P., Dhawan A., Sarkar S., p. 200-208.
- The effect of modafinil treatment on cravings in methamphetamine use disorder. Bardakçi M.R., Yazici A.B., Bardakçi S., Yazici E., p. 209-216.
- What differentiates dropping out from remaining in a brief intervention for problematic and dependent methamphetamine users? Rowicka M.M., p. 217-225.
- Psychotic-like experiences in young recreational users of ketamine: A case study. Ricci V., De Berardis D., Shoib S., Martinotti G., Maina G., p. 226-235.
- Ketamine-assisted psychotherapy for antisocial personality disorder: A case report. Hicks M.R., Zwickey H., Bradley R., p. 236-242.
- A psilocybin experience gone wrong: The importance of psychedelic assisted psychotherapy. Espi Forcen F., p. 243-245.
- Sex differences in religious beliefs before and after an entity encounter during an ayahuasca experience. Xin Y., Griffiths R.R., Davis A.K., p. 246-253.
- Death anxiety among users and non-users of psychedelics. Garcia A.C.M., Maia L.O., Meireles E., Nogueira D.A., Tofoli L.F., p. 254-264.
- Down the rabbit hole: A large-scale survey of psychedelic users' patterns of use and perceived effects. Cuttler C., Stueber A., Simone J., Mayo L.M., p. 265-277.
- Experimental test of perceptions of psychedelics by therapeutic and recreational use. Kiniry M.T., Magnan R.E., Elder S.N., Ladd B.O., p. 278-285.
- Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin use. Mathai D.S., Roberts D.E., Nayak S.M., Sepeda N.D., Lehrner A., Johnson M.W., et al., p. 286-297.
- Tripping into treatment: Comparing initial and current motivations for psychedelic use. Kruger D.J., Albrecht J., Aday J.S., Barron J., Herberholz M., Boehnke K.F., p. 298-304.
- Oregon's emerging psilocybin services workforce: A survey of the first legal psilocybin facilitators and their training programs. Luoma J.B., Hoffman K., Wilson-Poe A.R., Levander X.A., Bazinet A., Cook R.R., et al., p. 305-315.
- Drug use risks in Portuguese rural vs urban environments: Harm reduction challenges in a progressive drug policy setting. de Sousa Pinto M.S., Pires C.V., de Carvalho H., Pereira C.P., da Silva G.A.P., de Jesus Grilo Carapinha L., et al., p. 316-324.
- Cumulative social disadvantage and medicinal cannabis use among younger adults in rural communities: A mixed methods approach. Lipperman-Kreda S., Sanders E., Peach J., Brantley S., Hunt G., Antin T.M.J., p. 325-334.
- Consuming and thinking about nangs: A survey of nitrous oxide use, knowledge, attitudes and perceptions in Aotearoa New Zealand. Whelan J., John T., Crossin R., Ward R.D., p. 335-344.
- Clinical characteristics of health professions students with nitrous oxide use disorder. Angerville B., Szusterman A., Blecha L., Benyamina A., Naassila M., Dervaux A., p. 345-350.
- Approach without liking: The effects of smoking-related settings on implicit liking attitudes and approach tendencies toward smoking. Chen H., Zheng E., Lai K., Zhao B., Wei T., Gao L., et al., p. 351-360.
- Cannabis dependence among Georgian small-scale cannabis growers: Results of a cross-sectional online survey. Mgebrishvili T., Kirtadze I., Mirzazadeh A., Otiashvili D., p. 361-370.
- The Index of Cannabis Equivalence (ICE): A user-centered approach to standardization of cannabis dose-response. St Pierre M., Squires S., Daniels S., Sanchez T., Walsh Z., p. 371-376.